Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Microbix Biosystems Inc T.MBX

Alternate Symbol(s):  MBXBF

Microbix Biosystems Inc. develops and commercializes biological and technological solutions for human health and wellbeing. It enables the commercialization of diagnostic assays by making a range of critical ingredients and devices for the global diagnostics industry, notably antigens for immunoassays and its laboratory quality assessment products (QAPs) that support clinical lab proficiency testing, enable assay development and validation, or help ensure the quality of clinical diagnostic workflows. Its segments include development, manufacturing and sales of products relating to the medical diagnostics industry, namely antigens as test ingredients, quality assessment products to help ensure the accuracy of test workflows and viral transport medium to enable collection of patient test samples and, and development and commercialization of novel and proprietary products or technologies, such as Kinlytic. Its Kinlytic urokinase is a biologic thrombolytic drug used to treat blood clots.


TSX:MBX - Post by User

Bullboard Posts
Comment by ciretaka198on Mar 03, 2008 6:50pm
130 Views
Post# 14589236

RE: Patience ...Credability LOL

RE: Patience ...Credability LOLCredabilty? What happened to the 200 million anual revenue possiblities from the companion pet vacine due to come on starting 1998.What percentage of the market has MBX captured? Who is their stratigic partner that was due to sighn in 1998? This is past performance on a press release. How did they perform? Question? Did they have a sighning? Answer ; No. What percentage of the predicted 200 million anual revenue did they capture? Answer: None or at least almost none. This is just one example. Next let's look at their predictions for Urokinase none of that has happened yet either. GASTLE is a boy who cried wolf if I ever saw one? Nobody believes his B.S. anymore. He thinks he is pumping up shareolder value but he is not.He is killing it. 300 milliom there another 200 million over there.Look multimillion dollar revenue's are hiding behind every rock!! Sure they are billy. Sure they are.
Bullboard Posts